Thermo Fisher Scientific | TMO - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
Abbott USD 6.47B 525M 2026-09
Agilent USD 836M 9M 2026-06
Becton, Dickinson and Co. USD 2.58B 87M 2026-09
Bio Techne USD 101.68M 8.12M 2026-09
Bio-Rad Laboratories USD 305.2M 22.5M 2026-06
Boston Scientific USD 1.96B 93M 2026-09
Bruker USD 444.7M 22.2M 2026-09
Charles River Laboratories USD 632.47M 22.82M 2026-09
Danaher USD 2.72B 63M 2026-09
Dentsply International USD 393M 12M 2026-09
Edwards Lifesciences USD 369.2M 23.2M 2026-09
General Electric Aerospace USD 9.33B 439M 2026-09
Henry Schein USD 2.37B 61M 2026-09
Illumina USD 299M 90M 2026-09
Intuitive Surgical USD 964.4M 32.5M 2026-09
IQVIA Holdings USD 3.25B 26M 2026-09
Laboratory Of America USD 2.78B 83.4M 2026-09
Medtronic USD 3.83B 26M 2026-06
Mettler Toledo International USD 440.07M 43.55M 2026-09
Myriad Genetics USD 63M 1.1M 2025-12
Olympus JPY 78.06B 5.51B 2026-09
OraSure Technologies USD 15.43M 113K 2025-12
Quest Diagnostics USD 2.09B 38M 2026-09
Repligen USD 98.33M 4.24M 2026-09
Revvity USD 310.32M 2.5M 2026-09
Stryker USD 2.26B 106M 2026-06
Thermo Fisher Scientific USD 7.46B 72M 2026-09
Veracyte USD 45.07M 2.88M 2026-09
Waters USD 1.16B 430M 2026-06
Zimmer Biomet Holdings USD 760.5M 55.4M 2026-09